Immediate Impact
3 by Nobel laureates 3 from Science/Nature 52 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Zhongyi Yan being referenced
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
2020
A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Zhongyi Yan | 715 | 426 | 243 | 259 | 41 | 1.1k | |
| Masayuki Hiraki | 807 | 394 | 263 | 456 | 58 | 1.2k | |
| Shuangshuang Mao | 574 | 410 | 290 | 387 | 37 | 1.1k | |
| Xiang Long | 952 | 644 | 177 | 258 | 44 | 1.3k | |
| Qi-Shan Dai | 760 | 424 | 286 | 286 | 38 | 1.1k | |
| Lin Feng | 542 | 392 | 317 | 386 | 70 | 1.1k | |
| Dong Yang | 781 | 482 | 170 | 257 | 41 | 1.2k | |
| Ding Wang | 925 | 288 | 277 | 243 | 56 | 1.3k | |
| Bin Wang | 833 | 655 | 204 | 367 | 36 | 1.2k | |
| Rifat Hasina | 604 | 269 | 212 | 324 | 38 | 1.1k | |
| Qing‐Mei He | 861 | 630 | 134 | 275 | 43 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...